Atlas Trials

Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy

Clinical trial NCT04722133 · COMPLETED

Trial details

NCT number
NCT04722133
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
Start date
2020-06-23
Primary completion
2023-06-14
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.